Scleral Compromise in Hereditary Porphyria Cutanea Tarda
- PMID: 34084964
- PMCID: PMC8102938
- DOI: 10.4103/JOCO.JOCO_119_20
Scleral Compromise in Hereditary Porphyria Cutanea Tarda
Abstract
Purpose: To report a case of bilateral scleral compromise in a male patient with hereditary porphyria cutanea tarda (PCT).
Methods: Case report.
Results: A 57-year-old male was referred to the Cornea Service at Hospital de Clinicas in Buenos Aires for bilateral scleral thinning. He claimed ocular discomfort and photophobia. Slit-lamp biomicroscopy revealed an oval area of deep scleral thinning without uveal prolapse, adjacent to a conjunctival hyperemic zone in the interpalpebral area, 2 mm temporal to the limbus in the right eye. The left eye presented with a conjunctivalized scleral thinning in the interpalpebral area, 2 mm temporal to the limbus. Physical examination revealed facial hyperpigmentation and hypertrichosis and multiple hypopigmented scars in hands and nails. His family history was positive for PCT. The diagnosis was made by urine porphyrin test and genetic molecular testing. In an attempt to reduce ocular and systemic levels of porphyrins, the patient was treated with oral hydroxychloroquine and repeated phlebotomies, altogether with specially designed glasses to avoid local exposure to sunlight.
Conclusions: Scleral involvement is a rare manifestation of PCT. An adequate treatment, including interdisciplinary management may ameliorate ocular signs and symptoms.
Keywords: Eye protective devices; Porphyria; Porphyria cutanea tarda; Porphyria cutanea tarda/diagnosis; Scleral diseases.
Copyright: © 2021 Journal of Current Ophthalmology.
Conflict of interest statement
There are no conflicts of interest.
Figures




Similar articles
-
Sight-threatening progressive corneo-scleral involvement in porphyria cutanea tarda.BMJ Case Rep. 2021 Oct 19;14(10):e245160. doi: 10.1136/bcr-2021-245160. BMJ Case Rep. 2021. PMID: 34667041 Free PMC article.
-
Familial Porphyria Cutanea Tarda.2013 Jun 6 [updated 2022 Jun 9]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2013 Jun 6 [updated 2022 Jun 9]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 23741761 Free Books & Documents. Review.
-
Porphyria cutanea tarda in a human immunodeficiency virus-infected patient: A rare scenario in India.Indian J Sex Transm Dis AIDS. 2014 Jan;35(1):49-52. doi: 10.4103/0253-7184.132430. Indian J Sex Transm Dis AIDS. 2014. PMID: 24958988 Free PMC article.
-
Total Corneal Melt in Patient with Porphyria Cutanea Tarda in Presence of Another Risk Factor.Ocul Immunol Inflamm. 2019;27(4):610-613. doi: 10.1080/09273948.2017.1421231. Epub 2018 Jan 25. Ocul Immunol Inflamm. 2019. PMID: 29370566
-
[Porphyria cutanea tarda and hepatoerythropoietic porphyria].Nihon Rinsho. 1995 Jun;53(6):1427-32. Nihon Rinsho. 1995. PMID: 7616658 Review. Japanese.
References
-
- Park AJ, Webster GF, Penne RB, Raber IM. Porphyria cutanea tarda presenting as cicatricial conjunctivitis. Am J Ophthalmol. 2002;134:619–21. - PubMed
-
- Meyer UA. Porphyria. In: Braunwald E, Issebacher KJ, Petersdorf RG, Wilson JD, Martin JB, Fauci AS, editors. Harrison's Principles of Internal Medicine. 13th ed. McGraw-Hill: New York NY; 1994. pp. 2073–9.
Publication types
LinkOut - more resources
Full Text Sources